Found 50 matching trials
Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib PHASE2 The goal of this clinical trial was to evaluate whether zanubrutinib can ef...
Show More Location
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital
Learn More & Join Trial
A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia PHASE2 This was a single-arm, multicenter, Phase 2 study to evaluate the efficacy ...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment PHASE2 The primary objective of this study is to evaluate the safety of zanubrutin...
Show More Location
Rocky Mountain Cancer Centers (Williams) Usor
Learn More & Join Trial
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma PHASE2 Primary Objective: To compare the complete response rate (CR rate) after in...
Show More Location
Multiple Locations
Learn More & Join Trial
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma PHASE2 In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Show More Location
Henan cancer hospital
Learn More & Join Trial
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL PHASE2 This is a prospective, open-label, multicenter, randomized controlled study...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma PHASE2 This is a single arm study to evaluate the efficacy, safety and tolerabilit...
Show More Location
Clinical Research Alliance, Inc
Learn More & Join Trial
Zanubrutinib Combined With G-CVP in Previously Untreated FL PHASE2 The goal of this clinical trial is to learn the efficacy and safety of zanu...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T PHASE2 This is a phase ll study of participants with large B Cell lymphoma previou...
Show More Location
University Health Network (UHN)
Learn More & Join Trial
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL PHASE2 The purpose of this study is to compare the efficacy and safety of genotype...
Show More Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Learn More & Join Trial